Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18423312rdf:typepubmed:Citationlld:pubmed
pubmed-article:18423312lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C2350570lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C0025962lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C1522720lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C0178587lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:18423312lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18423312pubmed:issue5lld:pubmed
pubmed-article:18423312pubmed:dateCreated2008-4-21lld:pubmed
pubmed-article:18423312pubmed:abstractTextMalignant mesothelioma (MM) of the pleura is an aggressive and often fatal neoplasm. Because MM frequently demonstrates marked angiogenesis, it may be responsive to antiangiogenic therapy, but effective methods for selecting and monitoring of patients are further needed. We employed dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and quantitative immunohistochemistry (IHC) to characterize the microvascularity of MM using both a physiologic and ultrastructural method.lld:pubmed
pubmed-article:18423312pubmed:languageenglld:pubmed
pubmed-article:18423312pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423312pubmed:citationSubsetIMlld:pubmed
pubmed-article:18423312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423312pubmed:statusMEDLINElld:pubmed
pubmed-article:18423312pubmed:monthMaylld:pubmed
pubmed-article:18423312pubmed:issn1076-6332lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:WeberM AMAlld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:ChoykePeter...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:EssigMarcoMlld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:KnoppMichael...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:KauczorHans-U...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:KayserKlausKlld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:DelormeStefan...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:GieselFrederi...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:HintzeChristi...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:BischoffHelge...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:ZechmannChris...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:MehndirattaAm...lld:pubmed
pubmed-article:18423312pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:18423312pubmed:issnTypePrintlld:pubmed
pubmed-article:18423312pubmed:volume15lld:pubmed
pubmed-article:18423312pubmed:ownerNLMlld:pubmed
pubmed-article:18423312pubmed:authorsCompleteYlld:pubmed
pubmed-article:18423312pubmed:pagination563-70lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:meshHeadingpubmed-meshheading:18423312...lld:pubmed
pubmed-article:18423312pubmed:year2008lld:pubmed
pubmed-article:18423312pubmed:articleTitlePharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34).lld:pubmed
pubmed-article:18423312pubmed:affiliationRadiologie, German Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany. f.giesel@egiesel.comlld:pubmed
pubmed-article:18423312pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18423312lld:pubmed